Specific elements of the EU’s Artificial Intelligence (AI) Act, such as its data requirements, may result in less effective medtech products. Koen Cobbaert, senior manager, quality, standards, and regulations at Philips, reveals in the second part of a recent interview with Medtech Insight why updates to the draft AI Act text have not resolved hurdles for the medtech industry.
Which Parts Of The EU AI Act Are Unsuitable For Medtech?
Many computer science experts believe that the European Commission’s proposed AI Act is too legislatively heavy. In the second of a two-part interview series, Philips’ Koen Cobbaert explains what parts of the draft legislation are most troublesome for medtech.
